AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
1-Year Return
13.43%
This Quarter Return
-5.35%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$14.3B
AUM Growth
-$168M
(-1.2%)
Cap. Flow
+$13.4M
Cap. Flow
% of AUM
0.09%
Top 10 Holdings %
Top 10 Hldgs %
50.75%
Holding
806
New
78
Increased
577
Reduced
108
Closed
39
Top Buys
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
$603M |
| 2 |
OKS
Oneok Partners LP
OKS
|
$66.1M |
| 3 |
WES
Western Gas Partners Lp
WES
|
$57.3M |
| 4 |
NS
NuStar Energy L.P.
NS
|
$55.4M |
| 5 |
Plains All American Pipeline
PAA
|
$37.2M |
Top Sells
| 1 |
ETP
Energy Transfer Partners L.p.
ETP
|
$1.04B |
| 2 |
Enterprise Products Partners
EPD
|
$54.8M |
| 3 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$30.8M |
| 4 |
GG
Goldcorp Inc
GG
|
$19.8M |
| 5 |
Vanguard Small-Cap Value ETF
VBR
|
$13M |
Sector Composition
| 1 | Energy | 59.62% |
| 2 | Financials | 3.1% |
| 3 | Materials | 2.91% |
| 4 | Healthcare | 2.65% |
| 5 | Technology | 2.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
151
Vanguard Small-Cap Value ETF
VBR
$31.8B
| $3.92M | 0.03% |
31,925
-105,702
| -77% | -$13M |
|
|
BLUE
152
DELISTED
bluebird bio
BLUE
| $3.88M | 0.03% |
2,853
+140
| +5% | +$191K |
|
153
Galapagos
GLPG
$2.2B
| $3.51M | 0.02% |
45,868
+6,200
| +16% | +$474K |
|
154
Apple
AAPL
$3.56T
| $3.46M | 0.02% |
96,060
+30,336
| +46% | +$1.09M |
|
155
OGE Energy
OGE
$8.89B
| $3.45M | 0.02% |
99,012
+910
| +0.9% | +$31.7K |
|
156
Compass Diversified
CODI
$548M
| $3.37M | 0.02% |
+192,983
| New | +$3.37M |
|
157
NovaGold Resources
NG
$2.75B
| $3.34M | 0.02% |
732,631
-215,427
| -23% | -$982K |
|
158
Opko Health
OPK
$1.07B
| $3.32M | 0.02% |
504,924
+491,593
| +3,688% | +$3.23M |
|
159
Gold Fields
GFI
$30.8B
| $3.12M | 0.02% |
895,791
-557,773
| -38% | -$1.94M |
|
160
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$13.7B
| $3.1M | 0.02% |
30,432
+760
| +3% | +$77.3K |
|
161
Acadia Pharmaceuticals
ACAD
$4.26B
| $3.07M | 0.02% |
110,163
+5,968
| +6% | +$166K |
|
162
Simon Property Group
SPG
$59.5B
| $2.89M | 0.02% |
17,890
+2,500
| +16% | +$404K |
|
|
PTLA
163
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.89M | 0.02% |
51,468
+2,823
| +6% | +$159K |
|
164
Archrock
AROC
$4.44B
| $2.85M | 0.02% |
249,837
+21,019
| +9% | +$240K |
|
165
Equinix
EQIX
$75.7B
| $2.84M | 0.02% |
6,625
+20
| +0.3% | +$8.58K |
|
166
Supernus Pharmaceuticals
SUPN
$2.58B
| $2.78M | 0.02% |
64,533
+3,950
| +7% | +$170K |
|
167
Nektar Therapeutics
NKTR
$764M
| $2.74M | 0.02% |
+9,336
| New | +$2.74M |
|
|
ICPT
168
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.73M | 0.02% |
22,573
+1,231
| +6% | +$149K |
|
|
SAGE
169
DELISTED
Sage Therapeutics
SAGE
| $2.69M | 0.02% |
33,709
+1,734
| +5% | +$138K |
|
170
Public Storage
PSA
$52.2B
| $2.64M | 0.02% |
12,666
-30
| -0.2% | -$6.26K |
|
171
Prologis
PLD
$105B
| $2.64M | 0.02% |
44,942
-150
| -0.3% | -$8.8K |
|
|
ENDP
172
DELISTED
Endo International plc
ENDP
| $2.56M | 0.02% |
229,138
+24,983
| +12% | +$279K |
|
173
Ultragenyx Pharmaceutical
RARE
$3.07B
| $2.37M | 0.02% |
38,165
+2,267
| +6% | +$141K |
|
174
Welltower
WELL
$112B
| $2.3M | 0.02% |
30,770
-170
| -0.5% | -$12.7K |
|
175
Ligand Pharmaceuticals
LGND
$3.25B
| $2.29M | 0.02% |
30,269
+1,510
| +5% | +$114K |
|